Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival

Ion Mărunţelu; Claudiu Eduard Nistor; Bogdan Mihai Cristea; Corina Andreea Rotarescu; Andreea Mirela Caragea; Maria Tizu; Ileana Constantinescu

doi:10.12659/AOT.937267

12 August 2022: Original Paper

Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival

Ion Mărunţelu ^12ABCDEF , Claudiu Eduard Nistor ^2CEF* , Bogdan Mihai Cristea ^2CE , Corina Andreea Rotarescu ^12BCD , Andreea Mirela Caragea ^2B , Maria Tizu ^2B , Ileana Constantinescu ^12AD

DOI: 10.12659/AOT.937267

Ann Transplant 2022; 27:e937267

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Table 3 Outcome in patients with or without de novo HLA antibodies.

	With preexisting HLA antibodies n=27	With de novo HLA antibodies n=48	P value
T-cell-mediated rejection	13 (48.15%)	19 (39.58%)	0.627
Antibody-mediated rejection	7 (25.93%)	10 (20.83%)	0.775
HLA – human leukocyte antigen.

Back to the Article

Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival

Your Privacy